The Pinnacle Health Group
We’ve partnered with The Pinnacle Health Group to form a team of specialized reimbursement consultants who can help the billing or coding specialist in your office or organization. The Pinnacle Reimbursement Support Team is available live to respond to customer requests for reimbursement support.
The Reimbursement Support Team is competent to answer questions on several coding topics, such as:
- General coding and use of modifiers
- Benefit verification and prior authorization
- Appropriate claim completion
- Payer coverage
- Assistance with appeals and underpayments
The Pinnacle Reimbursement Support Team is available Monday through Friday, 8:30 a.m. to 6:00 p.m. ET. You can call them at 1-866-369-9290 or email the team at niox@thepinnaclehealthgroup.com.
Inside Sales Team
Do you have other questions about FeNO and your NIOX VERO®? As a NIOX customer, you already have a dedicated member of the Customer Experience Team ready and waiting for your call. Located at our offices in Morrisville, NC, your Inside Sales Team member works with you to ensure your needs are met.
The Inside Sales Team can answer your questions on:
- Order processing
- Set-up questions
- General product inquires
- Scheduling product training
- Information about FeNO monitoring with NIOX
- Provide information on coding and reimbursement
If you’ve got questions, we’ve got answers. You can call your Inside Sales Team member at 1-866-275-6469 or email the team at sales.us@niox.com.
NIOX® Customer Support and Training
At NIOX® we are passionate about providing excellent support and training.
References:
1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2021 update. 2. Kavanagh J et al. Over- and under-diagnosis in asthma. Breathe (Sheff). 2019;15(1):e20-e27. 3. Wang Z et al. Agency for Healthcare Research and Quality (AHRQ). The clinical utility of fractional exhaled nitric oxide (FeNO) in asthma management. Comparative Effectiveness Reviews, 197. 2017. 4. Petsky HL et al. Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis. Thorax. 2018;73(12):1110-1119. 5. Dweik RA et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602-15. 6. NIOX®. Data on File; MKT-DOF-007. 2023. 7. Menzies-Gow A et al. Clinical utility of fractional exhaled nitric oxide in severe asthma management. Eur Respir J. 2020;55(3):1901633. 8. NIOX®. NHS England Asthma data 2022 (AST001). QOF database. Available at; https://www.gpcontract.co.uk/browse/ENG/Asthma/22. Accessed; May 2023.